ONCOHOST
OncoHost's stories on HackerNoon
Technology evolves every day, impacting our lives more and more. Don’t miss out on the tech of tomorrow via these remarkable technology stories.
Meet the Winners of Startups in Asia
Wed Mar 02 2022 By Startups of The Year
Managing State in a React-Navigation App with Redux
Mon Jan 15 2018 By Andrea Bizzotto
Command Query Responsibility Segregation Separates Reading From Writing... but How?
Mon Jan 06 2025 By João Esperancinha
Helm 101: How to Create Helm Charts
Wed Feb 07 2024 By cloud-kung-fu
Ansible 101: Modularization & Debugging
Wed Jan 31 2024 By cloud-kung-fu
Ansible 101: Working With Facts and Templates
Tue Jan 30 2024 By cloud-kung-fu
Mastering Ansible Playbooks: A Guide to Task Controls & Handlers
Wed Jan 24 2024 By cloud-kung-fu
Declarative Engineering: Using Terraform to Code Your Data Pipelines
Thu Jan 18 2024 By Andrei Tserakhau
Hands On Mobile API Security: Pinning Client Connections
Thu May 25 2017 By Skip Hovsmith
OncoHost's latest news & mentions
Explore a rich selection of stories about your favorite games, how they are made, and the people that make them, from gamers and game developers worldwide.OncoHost to Present Proteomics-Based Predictive Biomarker for Immune-Related Adverse Events in NSCLC Patients at SITC 2023
lelezard.com
Tue Oct 31 2023
The who’s who of active investors in Israel’s startups
businesstimes.com.sg
Fri Oct 27 2023
With workers called to battle, Israeli firms rally support
israel21c.org
Tue Oct 17 2023
Clinical Trials - Phase III
biospace.com
Mon Oct 16 2023
Israeli startup founders go to war: 'We're fighting for our home.'
businessinsider.in
Fri Oct 13 2023
Israeli startup founders go to war: 'We're fighting for our home.'
businessinsider.in
Fri Oct 13 2023
Israeli startup founders go to war: 'We're fighting for our home.'
yahoo.com
Fri Oct 13 2023
Israeli startup founders go to war: 'We're fighting for our home.'
finance.yahoo.com
Fri Oct 13 2023
Israeli startup founders go to war: 'We're fighting for our home.'
finance.yahoo.com
Fri Oct 13 2023
Israeli startup founders go to war: 'We're fighting for our home.'
news.yahoo.com
Fri Oct 13 2023
Israeli startup founders go to war: ‘We’re fighting for our home.’
businessinsider.nl
Fri Oct 13 2023
Israel at War: A special message from OurCrowd
linkedin.com
Fri Oct 13 2023
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline
ascopubs.org
Thu Oct 12 2023
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline
ascopubs.org
Wed Oct 11 2023
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline
ascopubs.org
Wed Oct 11 2023
Gesund.ai Joins White House CancerX Initiative to End Cancer As We Know It
medindia.net
Thu Oct 05 2023
OncoHost, Hengenix Biotech Exploring Lung Cancer Resistance Biomarkers in Immunotherapy Trial
precisionmedicineonline.com
Tue Oct 03 2023
OncoHost, Hengenix Biotech Exploring Lung Cancer Resistance Biomarkers in Immunotherapy Trial
precisionmedicineonline.com
Tue Oct 03 2023
Nature Publishes Discovery and Preclinical Results for ABBV-CLS-484, a Potential First-in-Class PTPN2/N1 Inhibitor in Cancer Immunotherapy
medindia.net
Tue Oct 03 2023
Oncohost's Prophet® Platform To Support Henlius US-Based Phase III Trial For Patients With Extensive-Stage Small Cell Lung Cancer
menafn.com
Tue Oct 03 2023
OncoHost's PROphet® Platform to Support Henlius US-Based Phase III Trial for Patients with Extensive-Stage Small Cell Lung Cancer
fox8.com
Tue Oct 03 2023
Henlius and OncoHost partner to predict trial outcomes using machine learning
msn.com
Tue Oct 03 2023
OncoHost's PROphet® Platform to Support Henlius US-Based Phase III Trial for Patients with Extensive-Stage Small Cell Lung Cancer
finance.yahoo.com
Tue Oct 03 2023
OncoHost's PROphet® Platform to Support Henlius US-Based Phase III Trial for Patients with Extensive-Stage Small Cell Lung Cancer
benzinga.com
Tue Oct 03 2023
Representing this company? Click here to claim and customize this page!
Reviews About OncoHost
